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Abstract: The exact mechanisms of prion misfolding and factors that predispose an individual to prion diseases are largely 
unknown. Our approach to identifying candidate factors in-silico relies on contrasting the C-terminal domain of PrP
C 
sequences from two groups of vertebrate species: those that have been found to suffer from prion diseases, and those that 
have not. We propose that any signiﬁ  cant differences between the two groups are candidate factors that may predispose 
individuals to develop prion disease, which should be further analyzed by wet-lab investigations. Using an array of 
computational methods we identiﬁ  ed possible point mutations that could predispose PrP
C to misfold into PrP
Sc. Our results 
include conﬁ  rmatory ﬁ  ndings such as the V210I mutation, and new ﬁ  ndings including P137M, G142D, G142N, D144P, 
K185T, V189I, H187Y and T191P mutations, which could impact structural stability. We also propose new hypotheses that 
give insights into the stability of helix-2 and -3. These include destabilizing effects of Histidine and T188-T193 segment in 
helix-2 in the disease-prone prions, and a stabilizing effect of Leucine on helix-3 in the disease-resistant prions.
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Introduction
Misfolding of the prion protein (PrP) is believed to be responsible for the Transmissible Spongiform 
Encephalopathy (TSE) diseases (Prusiner, 1998). Experimental investigations suggest that the patho-
genesis of TSE is characterized by the unfolding of the normal Prion protein (PrP
C) followed by mis-
folding into an infectious “scrapie” isoform (PrP
Sc) (Pan et al. 1993). According to the protein-only 
hypothesis, PrP
Sc promotes structural conversion of the cellular PrP
C into the pathogenic conformation 
(Prusiner, 1998; Prusiner et al. 1998). The pathogenesis presumably involves the initial formation of 
PrP
Sc, which is a result of a point mutation(s) or some exogenous factors, and which subsequently 
interacts with and converts PrP
C molecules into PrP
Sc molecules. The last decade of research has pro-
vided a signiﬁ  cant amount of evidence that supports this hypothesis (Mead, 2006).
Known PrP
C structures reveal that the C-terminal domain (positions 125 to 230) is structured and 
contains three α-helices and a short β-sheet that includes two strands (see Fig. 1), whereas the N-terminal 
domain (positions 23 to 126) is highly ﬂ  exible and cannot be assigned a particular conformation (Riek 
et al. 1997; Riek et al. 1998; Lopez-Garcia et al. 2000). At the same time, the structure of the PrP
Sc 
isoform is currently still unknown.
Spectroscopic studies have shown that PrP
C is composed of about 42% α-helices and 3% β-sheets, 
whereas PrP
Sc is composed of only 30% α-helices and 43% β-sheets (Pan et al. 1993). Thus, the con-
formational transition of PrP
C into PrP
Sc has to involve unfolding of some α-helices and formation of 
new β-sheets. Helix-1 is the most conserved in PrP sequences and forms only a few interactions with 
the rest of the C-terminal domain. These facts led to a model in which helix-1 was considered as a 
starting point for conformational transition and forms a β-like aggregate, whereas helix-2 and helix-3 
retain their conformation (Huang et al. 1995; Morrisey et al. 1999; Wille et al. 2002). Some recent 
models of the pathologically misfolded form of PrP also show that the helix-1 region is unstable and 
has to unfold during the conformational transition (Eghiaian et al. 2004). At the same time, recent results 
provide strong evidence that helix-1 is not converted into a β-sheet during the aggregation of PrP
C to 
PrP
Sc (Watzlawik et al. 2006). This conclusion is also supported by experimental data obtained using 
low-resolution electron crystallography which suggest that helix-1 in PrP
Sc refolds into a left-handed 
β-helix (Wille et al. 2002), while subsequent work shows that helix-1 is not included in the β-helix but 134
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forms an unstructured loop (Govaerts et al. 2004). 
These discrepancies motivate this work, in which 
we use sequence based analysis to ﬁ  nd factors that 
could impact the stability of particular secondary 
structure segments.
A number of point mutations in the human prion 
have been identiﬁ  ed. A signiﬁ  cant proportion of 
all mutations are found within the structured 
C-terminal domain; 27 out of total of 30 as 
reported in (Kovacs et al. 2002) and 37 out of 55 
as reported in PrionDB at http://www.receptors.
org/Prion/ (Horn et al. 2001). Thus, we focus our 
attention on the C-terminal domain (see Fig. 1). 
Pathogenic mutations are classiﬁ  ed based on their 
association with prion diseases that include 
Gerstmann-Straussler-Scheinker disease (GSS), 
Creutzfeld-Jakob disease (CJD), and Fatal Familial 
Insomnia (FFI). The number of possible single-point 
mutations in the C-terminal domain is relatively 
large (109 positions * 19 = 2071), and thus it is not 
feasible to physically check every one of them 
using wet-lab techniques. Well-designed 
computational experiments (such as the design we 
propose) can reveal promising candidate factors, 
which serve as new hypotheses for wet-lab 
investigation. To this end, another of our goals is 
to use sequence based analysis to find point 
mutations that could predispose PrP
C to misfold 
into PrP
Sc.
In contrast to other sequence analysis based 
approaches that contrast prion proteins with struc-
turally similar proteins such as Doppel (Kuznetsov 
and Rackovsky, 2004), we present a novel in-silico 
approach based on the assumption that some 
species are susceptible and others are resistant to 
prion disease (PD). We divide the available prion 
LGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPCDEYSNQNNFVHDCVNITIK
      strand 1                      helix 1        strand 2       helix 2 
                     helix 3 
QHTVTTTTKGENFTETDVKMMERVVEQMCITQYERCSQAYYQR
M129M 
M129V 
G131V
I138M 
Y145stop
G142S
D147N
R148H
Q160stop S170N
N171S
F175W 
D178N
H178R
C179A
C179S
V180I
N181Q
T183A
H187R
T188K
T188R
E196K
F198S
D202N
V203I
R208H Q212P
C214A
E219K
T199A
E200K
M205V
V209L
M206L
V210I
E211Q
Q217R
Y218W
helix 3
helix 2
helix 1
strand 1  strand 2
Figure 1. Sequence and mutations in the C-terminal domain of huPrP together with the ribbon drawing of the corresponding 3D structure 
(positions 125 to 228 of 1HJM). The secondary structure segments are denoted by underscores. Bold indicates pathogenic mutations 
associated with the CJD phenotype, underline indicates GSS, and italic indicates FFI.135
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sequences from vertebrate animals into those that 
are prone to PD, and those that are apparently 
resistant, i.e. there are no reports of any known PD 
in that species and research suggests that they do 
not develop PD. We then compare the PrP 
sequences from these two groups (hereafter “the 
contrasts”), with a focus on the C-terminal domain. 
To the best of the authors’ knowledge, only two 
prior sequence-analysis-based contributions per-
form similar contrasting analysis, but they focused 
on identification of β-aggregating stretches 
(Tartagia et al. 2005) or contrasted just four prion 
proteins (Pappalardo et al. 2007). We used an array 
of computational techniques including multiple 
sequence alignment, exchange group similarities, 
and feature selection methods to identify possible 
factors that distinguish the contrasts for a larger 
set of 11 proteins. We suggest that such discrimi-
nating factors are potentially important in the 
conformational change from PrP
C to PrP
SC. The 
results of this analysis are best viewed as either 
evidence conﬁ  rming known factors associated with 
prion misfolding, or newly hypothesized factors 
that predispose the misfolding.
Materials and Methods
Dataset
We extracted the sequences of all prions that were 
deposited in Protein Data Bank (PDB) (Berman 
et al. 2000) as of September 2007. This database 
is expert-curated, which assures high quality of the 
data, and includes structural information, which 
allows us to identify secondary structure regions 
and perform structural analysis. The 70 prion 
sequences stored in PDB belong to 15 species: 
chicken (1 sequence), ovine (4 sequences), human 
(29), elk (1), rabbit (1), canine (1), frog (1), turtle 
(1), bovine (5), mouse (4), cat (1), pig (1), syrian 
hamster (2), sheep (5), and yeast (13). Yeast prions 
were removed since they have no homology with 
the remaining vertebrate prions, and are shown to 
have substantially different properties (Bousset and 
Melki, 2002). We ﬁ  ltered out redundant sequences, 
i.e. we selected the newest deposition for each 
species (except for sheep prions, for which there 
are two depositions from 2004; we selected the 
slightly older 1UW3 that does not include poly-
morphisms), and eliminated sequences that did not 
cover the C-terminal domain. We note that among 
the C-terminal domain sequences the four bovine 
sequences and the two mouse sequences are 
identical, while the only differences between the 
two sheep sequences are C148R and Q168H 
mutations, and among ten human prions nine 
sequences are identical and one differs from them 
by two mutations M166C and E221C. The positions 
associated with these mutations do not show any 
consistent pattern vs. our contrasts (i.e. they do not 
serve to differentiate PD-prone from PD-resistant 
species), and so the duplicate sequences are 
redundant and could be safely removed. It is in fact 
necessary to remove them; data-mining techniques 
such as feature selection assume that there is no 
redundancy in a dataset (deletion of redundant data 
items is a standard preprocessing step in data 
mining), and so the presence of redundant 
sequences would undermine our results.
Next, for the remaining 14 species we searched 
for evidence in the literature that supports existence 
of PD, or which suggests that they are PD resistant. 
Eight mammalian species (human, bovine, sheep, 
elk, cat, mouse, syrian hamster, and ovine) are 
shown to develop PD (Prusiner, 1997; Prusiner, 
1998; Benkel et al. 2007; Murayama et al. 2007). 
At the same time, prion diseases were never con-
firmed for the non-mammalian species turtle, 
chicken and frog, and several studies suggest that 
they do not develop prion diseases (De Simone 
et al. 2006; Ji et al. 2007). For the remaining 3 
species, i.e. pig, canine, and rabbit, we could not 
ﬁ  nd sufﬁ  cient evidence to categorize them to either 
class (Wells et al. 2003; Vorberg et al. 2003; Lysek 
et al. 2005). We note that canine shares high 
sequence similarity with PD-prone species, i.e. 
between 88% for human and 98% for cat, and 
moderate similarity with PD-resistant species, i.e. 
between 30% for frog and 41% for turtle. Similarly 
for rabbit and pig the sequence similarity to PD-
prone species ranges between 90% (for human) 
and 96% (for sheep and ovine), and between 86% 
(for hamster) and 93% (for elk), respectively, while 
for PD-resistant the similarity ranges between 31% 
(for frog) and 42% (for turtle), and between 28% 
(for frog) and 41% (for turtle), respectively. It is 
of course possible to simply add the three uncat-
egorized species to the “PD-resistant” class, since 
no evidence has been produced that they do expe-
rience prion disease. However, this would, in our 
view, be a serious methodological error. Our 
analysis contrasts species that are known to develop 
PDs against those that clearly do not, and this 
distinction directly affects all of the computational 136
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techniques (discussed below) that will be employed 
in our work. The inclusion of pig, canine and rabbit 
prions would undermine the contrasts, because we 
could not positively assert that these are truly PD-
resistant species. Our methods are fundamentally 
intended to identify only those differences that 
perfectly distinguish between the two classes; if 
the classes themselves become uncertain, our entire 
methodology becomes merely a “shotgun correla-
tion.” The eleven species we have selected already 
represent the maximal set of species that we can 
conﬁ  dently differentiate into our two classes at the 
present time. It would be highly desirable to 
include more species in each class; data-mining 
techniques such as feature selection are generally 
intended to operate over thousands or tens of thou-
sands of examples. Obtaining a ﬁ  rm determination 
of susceptibility to prion disease in canines, rabbits 
and pigs would be an excellent start.
Point mutations
We performed multiple sequence alignment of the 
11 PrP C-terminal domain sequences using Clust-
alW version 1.83 (Chenna et al. 2003). ClustalW 
produces biologically meaningful alignments that 
allow ﬁ  nding identities, similarities and differences 
between a set of protein sequences. Next, we 
searched for signiﬁ  cant mutations based on positions 
that are conserved within PD-prone and PD-resistant 
species. Each position was categorized as follows:
1. Each position that includes a conserved (the 
same) amino acid (AA) in the PD-prone species 
and a conserved (the same) AA (different from 
the AA conserved for the PD-prone) in the PD-
resistant species is categorized as signiﬁ  cant. 
Such a position shows conservation within each 
group while at the same time it differentiates 
the contrasts.
2. Each position that has different AAs over 
different PD-prone species and/or PD-resistant 
species is categorized as insigniﬁ  cant. These 
positions show no significant conservation 
pattern.
3.  Each position that has conserved (the same) AA 
over all PD-prone and resistant species is con-
sidered insigniﬁ  cant. Although these positions 
show signiﬁ  cant conservation, these residues 
do not differentiate the contrasts.
Working from the hypothesis that TSE mutations 
are exclusive to PD-prone species, each signiﬁ  cant 
position is a candidate factor that predisposes PrP
C 
to misfold into PrP
Sc.
We repeated the same procedure using exchange 
groups, which represent conservative replacements 
of AAs through evolution (Dayhoff et al. 1978). 
They relax the constraint of conservation by 
deﬁ  ning equivalence classes of AAs, as derived 
from the BLOSUM AA substitution matrix 
(Henikoff and Henikoff, 1992), which in turn was 
derived based on the BLOCKS database (Henikoff 
and Henikoff, 1991). This reduces the alphabet of 
20 AAs to the following six exchange groups: 
E1 ={H,R,K}, E2 = {D,E,N,Q}, E3 = {C}, 
E4 ={S,T,P,A,G}, E5 = {M,I,L,V}, and E6 = {F,Y,W}, 
and we consider a position to be conserved if all 
corresponding AAs belong to the same exchange 
group. We then label each position according to the 
three rules above, using exchange groups instead 
of individual AAs. Again, any position with con-
served (but different) exchange groups in PD-prone 
and resistant species is another candidate factor that 
predisposes PrP
C to misfold into PrP
Sc.
Stability of secondary structure
Each prion sequence was converted into a feature-
based vector, and the features that differentiate the 
contrasts were identiﬁ  ed using a combination of 
feature selection methods and correlation analysis. 
The features represent physicochemical properties 
of protein sequences that were previously used to 
characterize and predict certain properties related 
to the secondary structure of protein sequences, 
including structural class (Feng et al. 2005; Cao 
et al. 2006; Kedarisaetti et al. 2006; Kurgan and 
Chen, 2007) and secondary structure content 
(Zhang et al. 2001; Ruan et al. 2005; Homaeian 
et al. 2007). As such, features that discriminate 
between the contrasts are candidate factors that 
predispose β-sheet poor PrP
C to misfold into 
β-sheet rich PrP
Sc. As the conformational change 
from PrP
C to PrP
Sc will ultimately be driven by 
physiochemical properties, these features are a 
promising source of candidate factors. The fea-
tures we analyze include:
− Molecular  weight,  MolW (Kedarisaetti et al. 
2006; Homaeian et al. 2007), of a protein 
sequence is the result of adding up the average 
molecular weight MolWi values of its residues 
(see Table. 1) plus the mass of a water molecule 
(MolWHO 2 ) that is approximately 18 daltons137
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where N denotes the total number of residues 
in the sequence.
−  Average isoelectric point, pI (Kedarisaetti et al. 
2006; Kurgan and Chen, 2007; Homaeian et al. 
2007), of a protein sequence is computed based 
on the average isoelectric point pIi values of its 
residues (see Table. 1)
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− Composition  vector,  CV, and composition 
moment vector, CMV (Zhang et al. 2001; Feng 
et al. 2005; Ruan et al. 2005; Cao et al. 2006; 
Kedarisaetti et al. 2006; Kurgan and Chen, 2007; 
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Table 1. List of physicochemical amino acid indices and chemical groups used to derive features.
Amino acid Code Index Physicochemical index/chemical groups
MolW pI FH EH Associated chemical groups
Alanine A 1 71.0791 6.01 0.42 0.62 CH CO NH CH3
Cysteine C 2 103.1437 5.07 1.34 0.29 CH CO NH CH2 SH
Aspartate D 3 115.0887 2.77 −1.05 −0.9 CH CO NH CH2 CO COO
-
Glutamate E 4 129.1157 3.22 −0.87 −0.74 CH CO NH CH2 CH2 CO COO
-
Phenylalanine F 5 147.1772 5.48 2.44 1.19 CH CO NH CH2 CAROM 
CHAROM CHAROM CHAROM 
CHAROM CHAROM
Glycine G 6 57.0521 5.97 0 0.48 CH2 CO NH
Histidine H 7 137.1414 7.59 0.18 −0.4 CH CO NH CH2 CAROM 
CHAROM N CHAROM NH
Isoleucine I 8 113.16 6.02 2.46 1.38 CH CO NH CH2 CH CH3 CH3
Lysine K 9 128.1792 9.74 −1.35 −1.5 CH CO NH CH2 CH2 CH2 
CH2 NH3
+
Leucine L 10 113.16 5.98 2.32 1.06 CH CO NH CH2 CH CH3 CH3
Methionine M 11 131.1977 5.47 1.68 0.64 CH CO NH CH2 CH2 S CH3
Asparagine N 12 114.104 5.41 −0.82 −0.78 CH CO NH CH2 CO C NH2
Proline P 13 97.1171 6.48 0.98 0.12 CHRING CO NHRING CH2RING 
CH2RING CH2RING
Glutamine Q 14 128.131 5.65 −0.3 −0.85 CH CO NH CH2 CH2 CO C NH2
Arginine R 15 156.188 10.76 −1.37 −2.53 CH CO NH CH2 CH2 CH2 NH C 
NH2 NH2
+
Serine S 16 87.0784 5.68 −0.05 −0.18 CH CO NH CH2 OH
Threonine T 17 101.1054 5.87 0.35 −0.05 CH CO NH CH CH3 OH
Valine V 18 99.133 5.97 1.66 1.08 CH CO NH CH CH3 CH3
Tryptophan W 19 186.2139 5.89 3.07 0.81 CH CO NH CH2 CAROM 
CAROM CAROM NH CHAROM 
CHAROM CHAROM CHAROM 
CHAROM
Tyrosine Y 20 163.1756 5.67 1.31 0.26 CH CO NH CH2 CAROM 
CHAROM CHAROM CHAROM 
CHAROM CAROM OH138
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where nij represents the jth position of the ith 
amino acid, ni is the frequency of ith amino acid 
in the sequence, and k is the order of the CMV. 
We apply CMVs for k = 0, 1, 2. Note that CMVi
0 
reduces to CVi.
− Order  n hydrophobicity auto-correlation func-
tion, An
a (Zhang et al. 2001; Kedarisaetti et al. 
2006; Homaeian et al. 2007; Kurgan and Chen, 
2007), is computed by summing up the 
products of amino acid indices ai (see Table 1) 
of every pair of residues separated by 
n residues.
  A
Nn
aa n
a
ii n
i
Nn
=
−
+
=
−
∑
1
1
 
where a denotes the following hydrophobicity 
indices: Fauchere-Pliska’s (FH) index (Fauchere 
and Pliska, 1983) with n = 1,2, … ,10 and 
Eisenberg’s (EH) index (Eisenberg et al. 1984) 
with n = 1,2, … ,6.
− sum,  Hsum
a, average, Havg
a, and 3-point running 
average, Hsum3
a, of the above hydrophobicity 
indices, (Kedarisaetti et al. 2006; Homaeian 
et al. 2007; Kurgan and Chen, 2007)
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where a = {FH, EH}.
−  Composition of property groups, PGi, where i 
denotes a given property (Cao et al. 2006; 
Kedarisaetti et al. 2006; Homaeian et al. 2007; 
Kurgan and Chen 2007). AAs are clustered 
based on their properties (see Table 2) and com-
position is computed for each of the groups and 
subgroups. The hydrophobicity group includes 
hydrophilic and hydrophobic AAs. R group 
classiﬁ  cation is based on molecular weight, 
hydropathy and isoelectric point. Exchange 
groups cluster AAs based on accepted point 
mutations to represent conservative replacements 
Table 2. Property groups of amino acids used to derive features.
Groups Subgroups AAs Groups Subgroups AAs
R groups Nonpolar 
aliphatic
AVLIMG Hydrophobicity 
groups
Hydrophobic VLIMAFPWYCG
Polar 
uncharged
SPTCNQ Hydrophilic basic  KHR
Positively 
charged
KHR Hydrophilic acidic DE
Negative DE Hydrophilic polar 
with uncharged
side chain
STNQ
Aromatic FYW
Exchange 
groups
E1 KHR Electronic  groups Electron  donor DEPA
E2 DENQ Weak  electron
donor
VLI
E3 C Electron acceptor KNR
E4 AGPST Weak electron 
acceptor
FYMTQ
E5 ILMV Neutral GHWS
E6 FYW Special AA  C
Other groups Charged DEKHRVLI Other groups Tiny  AG
Polar DEKHRNTQSYW Bulky  FHWYR
Aromatic FHWY Polar-uncharged NQ
Small AGST139
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through revolution. Electronic group classiﬁ  cation 
is based on the tendency of AAs to accept or 
donate electrons. Other groups are deﬁ  ned based 
on molecular weights, polarity, aromaticity and 
charge. Finally, chemical groups are based on 
the composition of chemical groups that consti-
tute the side chains, see Table 1.
We employed three feature selection techniques 
to minimize bias in our results. These are the 
ReliefF (Robnik-Sikonja and Kononenko, 2003), 
information gain (Quinlan, 1993), and the χ
2 sta-
tistics, taken between a given attribute and the 
binary class (PD-prone/PD-resistant). The ReliefF 
algorithm estimates the ability of features to sepa-
rate classes. This algorithm examines nearest-
neighbors of a feature vector that belong to the 
same or a different class as the vector under con-
sideration. Features that categorize these nearest 
neighbors correctly receive a high score, and the 
process is repeated for each feature vector. The 
second selection technique is based on the concept 
of minimization of information entropy, while the 
chi-square statistic measures deviation from an 
assumed (normal) distribution of values for inde-
pendent variables. All three feature selection algo-
rithms are implemented in the WEKA data-mining 
software package (Witten and Frank, 2005). As a 
cross-check on the three selection algorithms, we 
also compute the bi-serial correlation between each 
feature and the binary class variable.
Results and Discussion
Point mutations
The aligned prion sequences are shown in Figure 2. 
Our analysis shows the following signiﬁ  cant posi-
tions: 137, 144, 187, 189, 191, and 210, which are 
associated with the following point mutations with 
respect to huPrP: P137M, D144P, H187Y, V189I, 
T191P, V210I (see Fig. 2). Similarly, when 
considering conservation at the level of exchange 
groups, the following positions were found sig-
niﬁ  cant: 137, 142, 144, 185, and 187. The positions 
137, 144, and 187 overlap with the results of residue 
conservation, while the remaining two positions are 
associated with G142D, G142N, and K185T point 
mutations. One mutation is a conﬁ  rmatory result, 
while the remaining eight are new ﬁ  ndings:
− P137M  (new  ﬁ  nding). Residues that compose 
helix-1 are not involved in hydrogen bonds with 
the rest of the C-terminal domain. This is true 
except for Y149 and Y150 which belong to 
helix- 1 and whose side chain hydroxyls donate 
to the carboxyl groups of D202 and the CO of 
P137 (Riek et al. 1998). Therefore, a mutation 
at P137 could further weaken interaction 
between helix-1 and the rest of the C-terminal 
domain. At the same time, several studies report 
importance of weakened interactions between 
helix-1 and other segments in the C-terminal 
domain on the folding into a stable native struc-
ture (Hirschberger et al. 2006; Schwarzinger 
et al. 2006; Eghiaian et al. 2007)
−  G142D and G142N (new ﬁ  ndings). A mutation 
at the same position, i.e. G142S, was previously 
classified as having a CJD-like phenotype 
(Gambetti et al. 2003). For this mutation, 
Glycine at position 142 was substituted with a 
polar, hydrophilic Serine. Using our approach, 
we identiﬁ  ed mutations at that position involv-
ing Aspartate and Asparagine, which are very 
similar to each other and both also polar and 
hydrophilic, similar to the known mutation.
− D144P  (new  ﬁ  nding). Previous research shows 
that D144 forms a salt bridge with H140, R148 
and R208 (Zuegg and Gready, 1999). The salt 
bridge between D144 and R208 links helix-1 
and helix-3, while the R208H mutation is asso-
ciated with CJD (Riek et al. 1998). Since salt 
bridges are suggested to increase the stability 
of proteins, mutation at this position could 
potentially lead to destabilization of the prion’s 
structure. Recent results also show that a point 
mutation leading to the disruption of a single 
salt bridge in p53 increases propensity to form 
amyloid ﬁ  brils (Galea et al. 2005).
− H187Y  (new  ﬁ  nding). This position is associ-
ated with a known H187R mutation that results 
in GSS (Cervenakova et al. 1999). At the same 
time, both Tyrosine and Arginine are polar and 
similar in size, i.e. their van der Waals volumes 
are 141 and 148, respectively.
− V210I  (conﬁ  rmatory ﬁ  nding). This mutation is 
well-known and is associated with CJD in 
humans (Riek et al. 1998).
We have shown that several of the new mutations 
we have found are closely related to known muta-
tions involved in TSE diseases, while others may 
impact structural stability of the prion protein. 
While we were unable to ﬁ  nd established research 
that would directly corroborate the remaining new 
mutations (K185T, V189I, and T191P), existing 140
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research indicates that mutations in this segment 
(which contains helix-2) may have β-sheet promot-
ing effects. Helix-2 is characterized by a strong 
propensity for the extended conformation, and a 
single AA replacement in the vicinity of this helix 
is shown to signiﬁ  cantly affect the conformational 
preference of the entire helix-2–helix-3 segment 
and to further increase the propensity for the 
extended conformation, facilitating conformational 
rearrangement in this region (Knaus et al. 2001; 
Kuznetsov and Rackovsky, 2004). These ﬁ  ndings 
also correlate well with the high number of disease-
promoting mutations in helices-2 and -3, which 
also points to the particular importance of these 
helices for conformational transition (only one 
disease-promoting mutation is found in helix-1 
while seven and eight such mutations are found in 
helix-2 and helix-3, respectively).
Stability of secondary structures
Our feature selection was performed using tenfold 
cross-validation to assure statistical validity for our 
results. Features are evaluated in each fold, and 
then they are ranked on their performance across 
all ten folds. Higher-ranked features have greater 
discriminatory power for the contrasts than 
position
a  121      130       140       150       160       170         180 
frog 1XU0 AAGAIGGYMLGNAVGRMSYQFNNPMESRYYNDYYNQMPNRVYRPMYRGEEYVSEDRFVRDCYNMSVT
turtle 1U5L VVGGLGGYALGSAMSGMRMNFDRPEERQWWNENSNRYPNQVYYKEYNDRSVPEGR-FVRDCVNITVT
chicken 1U3M VVGGLGGYAMGRVMSGMNYHFDRPDEYRWWSENSARYPNRVYYRDYSS-PVPQDV-FVADCFNITVT
mouse 1XYX VVGGLGGYMLGSAMSRPMIHFGNDWEDRYYRENMYRYPNQVYYRPVDQYSNQNN--FVHDCVNITIK
hamster 1B10 VVGGLGGYMLGSAMSRPMMHFGNDWEDRYYRENMNRYPNQVYYRPVDQYNNQNN--FVHDCVNITIK
bovine 1DWY VVGGLGGYMLGSAMSRPLIHFGSDYEDRYYRENMHRYPNQVYYRPVDQYSNQNN--FVHDCVNITVK
sheep 1UW3 ----LGGYMLGSAMSRPLIHFGNDYEDCYYRENMHRYPNQVYYRPVDQYSNQNN--FVHDCVNITVK
ovine 1Y2S VVGGLGGYMLGSAMSRPLIHFGNDYEDRYYRENMYRYPNQVYYRPVDRYSNQNN--FVHDCVNITVK
elk 1XYW   VVGGLGGYMLGSAMSRPLIHFGNDYEDRYYRENMYRYPNQVYYRPVDQYNNQNT--FVHDCVNITVK
cat 1XYJ   VVGGLGGYMLGSAMSRPLIHFGNDYEDRYYRENMYRYPNQVYYRPVDQYSNQNN--FVHDCVNITVR
human 1HJM ----LGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNN--FVHDCVNITIK
conservation
b                  ██
exch. Group
c                  ██ █ █
feature sel.
d                                                            █
position
a  186 190               200         210       220 
frog 1XU0 EYIIKPAEGKN--------NSELNQLDTTVKSQIIREMCITEYRRGS----------
turtle 1U5L EYKIDPNENQ---------NVTQVEVR--VMKQVIQEMCMQQYQQYQLASG------
chicken 1U3M EYSIGPAAKKNTSEAVAAANQTEVEMENKVVTKVIREMCVQQYREYRLAS-------
mouse 1XYX QHTVTTTTKGE--------NFTETDVK--MMERVVEQMCVTQYQKESQAYYDGRRSS
hamster 1B10 QHTVTTTTKGE--------NFTETDIK--IMERVVEQMCTTQYQKESQAYYDGRRS-
bovine 1DWY EHTVTTTTKGE--------NFTETDIK--MMERVVEQMCITQYQRESQAYYQRGA--
sheep 1UW3 QHTVTTTTKGE--------NFTETDIK--IMERVVEQMCITQYQRESQAYYQRGA--
ovine 1Y2S QHTVTTTTKGE--------NFTETDIK--IMERVVEQMCITQYQRESQAYYQRGAS-
elk 1XYW   Q HTVTTTTKGE--------NFTETDIK--MMERVVEQMCITQYQRESEAYYQRGAS-
cat 1XYJ   Q HTVTTTTKGE--------NFTETDMK--IMERVVEQMCVTQYQKESEAYYQRRAS-
human 1HJM QHTVTTTTKGE--------NFTETDVK--MMERVVEQMCITQYERESQAYYQR----
conservation
b ███ █
exch. group
c █
feature sel.
d ██ ████ █ █ █
Figure 2. Results of sequence alignment between the three PD-resistant prions (top) and the eight PD-prone prions (identiﬁ  ed by the PDB 
ID for the protein).
aPositions are encoded with respect to the huPrP.
b“  Conservation” line shows positions (black squares with the corresponding residues shown in bold) that were signiﬁ  cant based on the 
conservation of amino acids.
c“  Exch. group” line shows positions (black squares with the corresponding residues underlined) that were signiﬁ  cant based on the conserva-
tion of amino acids grouped in exchange groups.
d“  Feature sel.” line shows positions (black squares with the corresponding residues denoted by dotted line boxes) that were signiﬁ  cant based 
on the feature selection.141
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lower-ranked ones. We average the ranks reported 
for each feature across our three feature selection 
methods. We report the top ﬁ  ve features, ordered 
by average rank, which have biserial correlation 
coefﬁ  cient values 0.9 in Table 3. The biserial 
correlation coefficient measures correlations 
between ratio-scale and binary variables, and is 
interpreted in the usual manner (values 0.8 indi-
cate strong correlations).
The ﬁ  ve features in Table 3 fall into two groups: 
those that show higher values for PD-prone species 
than PD-resistant species, and those that show 
higher values for PD-resistant species than PD-
prone species. We begin our discussion with the 
former group. The second feature in Table 3 is 
related to the composition of the N group in the 
AA side chains. Since N group occurs only in 
Histidine, this feature indicates that presence of 
this AA is speciﬁ  c to one group of prion proteins. 
This ﬁ  nding is also supported by the third feature, 
CMVH
1, which reveals additional details. Values 
of these two correlated features for the ten prion 
sequences are shown in Figure 3(a). The plots 
shows higher values of the composition moment 
vector for Histidine for the PD-prone species when 
compared with the PD-resistant species. Since the 
composition moment values are proportional to the 
distance of the corresponding residue from the N-
terminal, high values indicate the presence of 
Histidine near the C-terminal in the PD-prone 
prions. Figure 2 shows two highly conserved His-
tidine positions in helix-2, i.e. 177 and 187, that 
are speciﬁ  c to PD-prone prions, while the only 
position in the PD-resistant chicken prion that 
contains Histidine is 140. This ﬁ  nding is supported 
by prior research which shows that charged Histi-
dine side chains in the middle of α-helices have a 
destabilizing effect on the structure because of the 
unfavorable interaction with the helix macrodipole 
(Armstrong and Baldwin, 1993). This destabilizing 
effect in the context of protonation of H187 
(Langella et al. 2004) provides some explanation 
for the weak stability of helix-2. We note that this 
ﬁ  nding can also be related to the H187R mutation, 
associated with GSS.
The CMVT
1 feature, which again is character-
ized by higher values for PD-prone species (see 
Fig. 3A) reveals that Threonine is signiﬁ  cantly 
more abundant in this group of species. Figure 2 
reveals that a highly conserved TVTTTT segment 
in helix-2 is speciﬁ  c to these prions. This segment 
is surface exposed and located between two gly-
cosylation sites and most likely “covered” by the 
glycan side chains. It was previously found to be 
signiﬁ  cant in the context of a potential molecular 
mechanism leading to the destabilization of the 
helix-2 segment, which postulates formation of a 
hydrogen bond between residues T188 and T193 
that drives the unwinding of the α-helix 
(Pappalardoa et al. 2004). Another study that 
looked into the TTTT sub-segment (positions 
190–193) concluded that this sub-segment is 
usually found in a strand and/or loop conformation 
and that the second half of helix-2 would be better 
accommodated in non-helical conformations 
(Dima and Thirumalai, 2004).
In contrast, the remaining two features have 
higher values for the PD-resistant prions; see 
Figure 3B. Analysis of the aligned sequences 
shown in Figure 2 reveals that although Leucine 
is present at positions 125, 130, and 138 in both 
types of prions, this AA is only present in the vicin-
ity of the C-terminal in the PD-resistant prions. As 
a result, positions 200, 203, and 223 (located within 
helix-3) were identiﬁ  ed as signiﬁ  cant locations 
based on the position-sensitive CMVL
2 feature (see 
Fig. 2). Recent computational analysis of local 
interactions that promote formation of secondary 
structures shows that Alanine, Glutamine, Gluta-
mate, and Leucine are strongly associated with 
formation of helices (Chen et al. 2006). We also 
note that positions 200 and 203 are associated with 
known mutations. Position 203 is associated with 
the V203I mutation that causes CJD (Peoc’h et al. 
2000). E200K, which results in CJD, is one of the 
most common worldwide prion mutations (Mead, 
2006). This mutation results in loss of a salt-bridge 
interaction between the side chains of E200 and 
K204 (Zhang et al. 2000). In the native huPrP these 
side chains are intimately juxtaposed (within 5 Å) 
and therefore they could be involved in a salt 
bridge. In the E200K mutant protein, the nearest 
negatively charged side chain to E200 is that of 
Table 3. Top ﬁ  ve features that differentiate between 
PD-prone and resistant prions.
Feature Avg.  rank  Bi-serial  correlation
   coefﬁ  cient
CMVP
1 7.6  0.97
Chemical N group  9.3  0.94
CMVH
1 11.1  0.97
CMVT
1 12.2  0.96
CMVL
2 12.8  0.99142
Kedarisetti et al
Bioinformatics and Biology Insights 2008:2 
D196 which is 13 Å from E200 (Zhang et al. 2000). 
Therefore, mutation on this position could result 
in destabilization of the structure.
Finally, the CMVP
1 feature indicates that loca-
tion 191, which contains a highly conserved Pro-
line residue, is speciﬁ  c to the PD-resistant prions 
(see Fig. 2). We were unable to find existing 
research that would corroborate the signiﬁ  cance 
of this position, due to the limited amount of work 
on non-mammalian prions.
Conclusions
We present a novel, in-silico approach to identify 
factors related to misfolding of prion proteins. We 
contrasted PrP
C sequences of the C-terminal 
domains of PD-prone and PD-resistant species. 
The analysis focused on ﬁ  nding signiﬁ  cant point 
mutations and investigating structural stability of 
secondary structures that comprise the C-terminal 
domain. We conﬁ  rmed the V210I mutation, which 
is associated with CJD, and present several new 
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Figure 3. Values of top ﬁ  ve features for the 11 prion sequences: features that indicate abundance of the associated amino acids in A) PD-prone 
prions, and B) PD-resistant prions. The ﬁ  rst three sequences correspond to the PD-resistant prions, and the remaining sequences to the 
PD-prone prions.143
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findings that include P137M, G142D, G142N, 
D144P, K185T, V189I, H187Y and T191P mutations; 
destabilizing effects of Histidine and the T188-T193 
segment on stability of helix-2 in the PD-prone 
prions; and stabilizing effects of Leucine on helix-3 
in the PD-resistant species. All of these new ﬁ  ndings 
are possible candidate factors that could inﬂ  uence 
conformational change from PrP
C to PrP
Sc. They 
are a new set of hypotheses that should be investi-
gated via wet-lab experimentation or (at a minimum) 
molecular dynamics simulations. In addition, if and 
when additional species can be deﬁ  nitively classiﬁ  ed 
as PD-prone or PD-resistant, it would be quite inter-
esting to repeat our experiments with these additional 
species included in the contrasts. Finally, we note 
that the resistance to prion diseases of the PD-
resistant species could be a result of other factors 
besides the differences in their sequences, which 
should be addressed in future studies.
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